Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-23-002264)

Filing Details

Accession Number:: 0001437749-23-002264
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-01 16:37:17
Reporting Period:: 2023-01-30

Accepted Time:: 2023-02-01 16:37:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1029125	Panbela Therapeutics Inc.	PBLA	Pharmaceutical Preparations (2834)	870543922

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1545253	K. Jennifer Simpson	712 Vista Blvd #305 Waconia MN 55387	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-30	4,444	$0.00	7,868	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2023-01-30	8,888	$0.00	8,888	$2.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,888	2023-01-30	2028-01-30	No	4	P	Direct

Footnotes

Reported securities purchased as one share of common stock and one warrant to purchase two shares of common stock for a combined price of $2.25 per share and warrant.
On or after March 1, 2023, holder may elect an "alternative cashless exercise" pursuant to which they would receive an aggregate number of shares of common stock equal to 75% of the aggregate number of shares that would be issuable upon a cash exercise.